Gaush Meditech (HKSE:02407) EV-to-EBIT : -10.58 (As of May. 26, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Gaush Meditech's Enterprise Value is HK$2,611.3 Mil. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil. Therefore, Gaush Meditech's EV-to-EBIT for today is -10.58.

The historical rank and industry rank for Gaush Meditech's EV-to-EBIT or its related term are showing as below:

HKSE:02407' s EV-to-EBIT Range Over the Past 10 Years
Min: -81.01 Med: -14.84 Max: 15.82
Current: -10.58

During the past 5 years, the highest EV-to-EBIT of Gaush Meditech was 15.82. The lowest was -81.01. And the median was -14.84.

HKSE:02407's EV-to-EBIT is ranked worse than
100% of 458 companies
in the Medical Devices & Instruments industry
Industry Median: 20.17 vs HKSE:02407: -10.58

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Gaush Meditech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,426.8 Mil. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil. Gaush Meditech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -4.55%.

Gaush Meditech EV-to-EBIT Historical Data

The historical data trend for Gaush Meditech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech EV-to-EBIT Chart

Gaush Meditech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-29.21

16.63

Gaush Meditech Semi-Annual Data
	Dec19	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-29.21	-	16.63

Competitive Comparison of Gaush Meditech's EV-to-EBIT

For the Medical Devices subindustry, Gaush Meditech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Gaush Meditech's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's EV-to-EBIT falls into.

Gaush Meditech EV-to-EBIT Calculation

Gaush Meditech's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	2611.321	/	-246.754
	=	-10.58

Gaush Meditech's current Enterprise Value is HK$2,611.3 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil.

Gaush Meditech (HKSE:02407) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Gaush Meditech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	-246.754	/	5426.836
	=	-4.55 %

Gaush Meditech's Enterprise Value for the quarter that ended in Dec. 2023 was HK$5,426.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was HK$-246.8 Mil.

Gaush Meditech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Gaush Meditech (HKSE:02407) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

F7Y:Germany

Address

No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN

Website

https://www.gaush.com

Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.

Executives

Orbimed Advisors Iii Limited	2102 Investment manager
Orbimed Asia Gp Iii, L.p.	2102 Investment manager
Orbimed Asia Partners Iii, L.p.	2102 Investment manager
Gao Tieta	2201 Interest of corporation controlled by you
Gaush Holding Ltd	2101 Beneficial owner
Cuprite Gem Investments Ltd	2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd.	2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc	2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p.	2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p.	2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p.	2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines